글로벌 크림콩고 출혈열 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 크림콩고 출혈열 시장

글로벌 크림콩고 출혈열 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 4.60%의 CAGR로 성장할 것으로 분석합니다.

크림콩고 출혈열은 나이로바이러스라는 진드기 매개 바이러스에 감염되어 발생하는 바이러스성 질환으로, Bunyaviridae과에 속합니다. 진드기 물림으로 인해 감염되면 잠복기는 1~3일, 최대 9일입니다. 그러나 감염된 혈액이나 조직과의 접촉으로 인해 감염되면 잠복기는 보통 5~6일, 최대 13일입니다. 증상으로는 두통 , 발열, 근육통, 요통, 복통, 메스꺼움, 설사, 림프절 종대, 빈맥이 있습니다 .

질병 유병률 증가, 의료비 지출 증가, 건강과 더 나은 위생에 대한 인식 증가는 글로벌 크림콩고 출혈열 시장을 확대할 요인입니다. 또한, 사람들에게 바이러스에 노출되는 것을 피하기 위한 위험 요소와 조치에 대한 교육, 정부 자금 지원 증가, 정부와 비정부 기구의 이니셔티브 증가는 시장 성장을 촉진할 것입니다 .

연구 개발 활동의 증가와 임상 시험 수의 급증은 2021~2028년 예측 기간 동안 글로벌 크림콩고 출혈열 시장에 유익한 기회를 제공할 것입니다.

However, high cost of medication,lack of cure and the available treatment is supportive are the factors that will hinder the market growth and will further challenge the global crimean-congo haemorrhagic fever market in the forecast period mentioned above.

This crimean-congo haemorrhagic fever market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the crimean-congo haemorrhagic fever market contact Data Bridge Market Research for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Crimean-Congo Haemorrhagic Fever Market Scope and Market Size

The crimean-congo haemorrhagic fever market is segmented on the basis of treatment, diagnosis, transmission, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the crimean-congo haemorrhagic fever market is segmented intoribavirin, histamine receptor blockers, steroids, anti-CCHF monoclonal antibodies, intravenous immunoglobulin (IVIG) and others.
• On the basis of diagnosis, the crimean-congo haemorrhagic fever market is segmented intoenzyme-linked immunosorbent assay (ELISA), serum neutralization, antigen detection, reverse transcriptase polymerase chain reaction (RT-PCR) assayand others.
• On the basis of transmission, the crimean-congo haemorrhagic fever market is segmented intotransstadial, transovarial and others.
• On the basis of dosage, the crimean-congo haemorrhagic fever market is segmented into injection, tablet, capsule and others.
• On the basis of route of administration, the crimean-congo haemorrhagic fever market is segmented into intravenous, oral and others.
• On the basis of end-users, the crimean-congo haemorrhagic fever market is segmented into clinic, hospital and others.

The crimean-congo haemorrhagic fever market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Crimean-Congo Haemorrhagic Fever Market Country Level Analysis

Crimean-congo haemorrhagic fever market is analyzed and market size information is provided by the country, treatment, diagnosis, transmission, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the crimean-congo haemorrhagic fever market reportare the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates thecrimean-congo haemorrhagic fever market due to the presence of major key players, well-developed healthcare sector, advancement in treatment options and increasing awareness towards rare diseases in this region. Asia-Pacific is expected to grow during the forecast period 2021 to 2028 due to the increasing research and development activities, increasing prevalence of the disease, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Crimean-congo haemorrhagic fever market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Crimean-Congo Haemorrhagic Fever MarketShare Analysis

크림콩고 출혈열 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 포함됩니다. 위에 제공된 데이터 포인트는 크림콩고 출혈열 시장과 관련된 회사의 초점에만 관련이 있습니다.

크림콩고 출혈열 시장 보고서에 포함된 주요 기업으로는 Aurobindo Pharma, Zydus Pharmaceuticals, Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Albany Molecular Research Inc. (AMRI), Siegfried Holding AG, TRIMAX, Novartis AG, Sanofi, Pfizer Inc., GlaxoSmithKline plc, Merck KGaA, Sumitomo Corporation, Johnson & Johnson Private Limited, AstraZeneca, Abbott, Cipla Inc., Bayer AG, LEO Pharma A/S, Grifols, SA, Takeda Pharmaceutical Company Limited, Biotest AG., Bio Products Laboratory Ltd., Baxter 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-65913